A detailed history of Pictet Asset Management Holding Sa transactions in Moderna, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 1,114,162 shares of MRNA stock, worth $73.3 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,114,162
Previous 2,621,637 57.5%
Holding current value
$73.3 Million
Previous $279 Million 52.64%
% of portfolio
0.15%
Previous 0.31%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$101.21 - $166.61 $153 Million - $251 Million
-1,507,475 Reduced 57.5%
1,114,162 $132 Million
Q1 2024

May 14, 2024

BUY
$85.37 - $115.44 $70.4 Million - $95.1 Million
824,187 Added 45.85%
2,621,637 $279 Million
Q4 2023

Feb 13, 2024

BUY
$69.51 - $104.43 $28.3 Million - $42.5 Million
407,441 Added 29.31%
1,797,450 $179 Million
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $134 Million - $176 Million
1,390,009 New
1,390,009 $144 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Pictet Asset Management Holding Sa Portfolio

Follow Pictet Asset Management Holding Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Holding Sa with notifications on news.